ACTIVE SUBSTANCE / INN

CLONIDINE

Brand name(s): NEXICLON XR, CATAPRES-TTS-2, CATAPRES-TTS-1, CLONIDINE, CATAPRES-TTS-3
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA076166
NDA022500
ACTIVE SUBSTANCE
Clonidine
REGULATORS
FDA
SPONSORS / MAH
LAVIPHARM, MYLAN TECHNOLOGIES, ATHENA
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CATAPRES-TTS-3NDA018891LAVIPHARMPrescription
CATAPRES-TTS-1NDA018891LAVIPHARMPrescription
CATAPRES-TTS-2NDA018891LAVIPHARMPrescription
CLONIDINEANDA076157DIFGEN PHARMSDiscontinued
CLONIDINEANDA076166MYLAN TECHNOLOGIESPrescription
NEXICLON XRNDA022500ATHENAPrescription
NEXICLON XRNDA022500ATHENADiscontinued

FULL INTELLIGENCE ON CLONIDINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →